本页面由Tiger Trade Technology Pte. Ltd.提供服务

曼恩凯德生物医疗

3.13
-0.1600-4.86%
盘后:3.170.0400+1.28%19:47 EDT
成交量:395.70万
成交额:1,238.70万
市值:10.06亿
市盈率:-22.36
高:3.27
开:3.24
低:3.08
收:3.29
52周最高:6.51
52周最低:2.23
股本:3.22亿
流通股本:3.10亿
量比:0.94
换手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-0.1400
每股收益(LYR):0.0200
净资产收益率:32.74%
总资产收益率:0.79%
市净率:-14.98
市盈率(LYR):156.50

数据加载中...

2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

重要事件披露

Form 8-K - Current report
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities